2026 SPS Denver | Clinical and Practice Considerations for the Use of Taletrectinib in Non-Small Cell Lung Cancer Setting (NSCLC)

2026 SPS Denver | Clinical and Practice Considerations for the Use of Taletrectinib in Non-Small Cell Lung Cancer Setting (NSCLC)

0% Complete

Course Overview

NA

Course Content

Course Details

Duration
0.00 hour
Released
May 23, 2026
Last Review
May 23, 2026
Expires
May 23, 2029

Objectives

NA

Target Audience

Pharmacists

Faculty & Disclosure

Faculty

Jorge J. Garcia, PharmD, MS, MHA, MBA, FACCC, FACHE

Disclosure

NA

Accreditation

NA